Lubrano, E., Scriffignano, S. & Perrotta, F. M. Psoriatic arthritis, psoriatic disease, or psoriatic syndrome? J. Rheumatol. 46, 1428–1430 (2019).

Article  PubMed  Google Scholar 

Gossec, L. et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Ann. Rheum. Dis. https://doi.org/10.1136/ard-2024-225531 (2024).

Gossec, L. et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Ann. Rheum. Dis. 79, 700–712 (2020).

Article  PubMed  Google Scholar 

Coates, L. C. et al. GRAPPA Treatment Recommendations domain subcommittees. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. Nat. Rev. Rheumatol. 18, 465–479 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Coates, L. & Gossec, L. The updated GRAPPA and EULAR recommendations for the management of psoriatic arthritis: similarities and differences. Joint Bone Spine 90, 105469 (2023).

Article  PubMed  Google Scholar 

Coates, L. C. et al. Enhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panel. Rheumatology https://doi.org/10.1093/rheumatology/keae172 (2024).

Ytterberg, S. R. et al. ORAL Surveillance Investigators. Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis. N. Engl. J. Med. 386, 316–326 (2022).

Article  CAS  PubMed  Google Scholar 

Queiro, R. et al. Severe disease in patients with recent-onset psoriatic arthritis. Prediction model based on machine learning. Front. Med. 28, 891863 (2022).

Article  Google Scholar 

Lubrano, E., Scriffignano, S., Fatica, M. & Perrotta, F. M. Potential differences in clinical features, disease activity, function and impact of disease between oligo and polyarticular psoriatic arthritis. J. Psoriasis Psoriatic Arthritis 6, 38–42 (2021).

Article  Google Scholar